Curcumin as a protector for normal cells during bortezomib therapy

Human and Experimental Toxicology

Volumn 34, Issue 7, 2015, Pages 780-783

  Kumar, R R ^a   Malhotra, A ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

cancer biology; Drug toxicology; oxidative stress

Indexed keywords

BORTEZOMIB; CURCUMIN; HEMOGLOBIN; PORPHOBILINOGEN SYNTHASE; ANTINEOPLASTIC AGENT; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BLOOD TOXICITY; CANCER THERAPY; CELL PROTECTION; CLINICAL EVALUATION; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; MALE; MOUSE; MYELOMA; NONHUMAN; PRIORITY JOURNAL; TOXICITY TESTING; ANIMAL; BLOOD; DRUG EFFECTS; METABOLISM;

MUS;

ANIMALS; ANTINEOPLASTIC AGENTS; BORTEZOMIB; CURCUMIN; ERYTHROCYTES; HEMOGLOBINS; MALE; MICE; PORPHOBILINOGEN SYNTHASE; PROTECTIVE AGENTS;

EID: 84931352464     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327114555928     Document Type: Article

References (24)

1. Bonvini P, Zorzi E, Basso G, et al. Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma. Leukemia. 2007 ; 21 (4). 838-842
2. Liu F-T, Agrawal SG, Movasaghi Z, et al. Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib. Blood. 2008 ; 112 (9). 3835-3846
3. Montagut C, Rovira A, Albanell J. The proteasome: a novel target for anticancer therapy. Clin Trans Oncol. 2006 ; 8 (5). 313-317
4. Rajkumar SV, Richardson P, Hideshima T. Proteasome inhibition as a novel therapeutic target in human cancer. J Clin Oncol. 2005 ; 23: 630-639
5. Landowski TH, Megli CJ, Nullmeyer KD. Mitochondrial mediated disregulatioin of Ca2+ is a critical determinant of velcade cytotoxicity in myeloma cell lines. Canc Res. 2005 ; 62: 4996-5000
6. Richardson PG, Barlogie B, Berenson J. A phase 2 study of bortezomib in relapsed, refractory myeloma. New Eng J Med. 2003 ; 348: 2609-2617
7. Mallhotra A, Nair P, Dhawan DK. Study to evaluate molecular mechanics behind synergistic chemo-preventive effects of curcumin and resveratrol during lung carcinogenesis. Plos One. 2014 ; 9 (4). e93820
8. Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutrit. 2010 ; 134: 3479S - 3485S
9. Malhotra A, Nair P, Dhawan DK. Curcumin and resveratrol in combination modulates benzo(a)pyrene induced genotoxicty during lung carcinogenesis. Hum Exp Toxicol. 2011 ; 31 (12). 1199-1206
10. Haeger-Aronsen B, Schutz A. Antagonistic effect in vivo of zinc on inhibition of delta-aminolevulinic acid dehydratase by lead. Arch Environ Health. 1978 ; 31 (4). 215-220
11. Heloisa E, Palma PW, Miguel G. Oxidative stress parameters in blood, liver, and kidney of diabetic rats treated with curcumin and/or insulin. Mol Cell Biochem. 2014 ; 386 (1-2). 199-210
12. Muthumani M. Tetrahydrocurcumin potentially attenuates arsenic induced oxidative hepatic dysfunction in rats. J Clin Toxicol. 2013 ; 3: l68
13. Smith AF, Morgan GJ, Davies FE. Bortezomib in the treatment of multiple myeloma. Ther Clin Risk Manag. 2006 ; 2 (3). 271-279
14. Swarnakar S, Ganguly K, Kundu P, et al. Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem. 2005 ; 280 (10). 9409-9415
15. Ceballos-Picot I, Triever JV, Nicole A, et al. Age-correlated modifications of copper-zinc superoxide dismutase and glutathione-related enzyme activities in human erythrocytes. Clin Chem. 1992 ; 38 (1). 66-70
16. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurements with the Folin-phenol reagent. J Biol Chem. 1951 ; 193: 265-275
17. Helen BB, Abraham LS. Improved method for measurement of delta-aminolevulinic acid dehydratase activity of human erythrocytes. Clin Chem. 1971 ; 17: 1038-1041
18. Dacie JV, Lewis SM Practical hematology. 6 th ed. London: Churchill, 1991. London: Churchill ; 1991 :
19. Antonia FS, Gareth JM, Faith ED. Bortezomib (Velcade™) in the treatment of multiple myeloma. Ther Clin Risk Manag. 2006 ; 2 (3). 271-279
20. Warin L, Rosawan S, Suganya S. Cerulopasmin oxidase activity as a biomarker of lead exposure. J Occup Health. 2005 ; 57: 56-60
21. Flora SJS, Pant BP, Tripathi N, et al. Theraleutic efficacy of a few diesters of meso dimercaptosuccinic acid during sub-chronic arsenic intoxication in rats. J Occup Health. 1997 ; 39: 119-123
22. Simons TJ. The affinity of human erythrocyte prophobilinogen synthase for Zn2+ and Pb2+. Eur J Biochem. 1995 ; 234: 178-183
23. Gibbs PNB, Gore MG, Jordan PM. Investigation of the effect of metal ions on the reactivity of thiol groups in human δ-aminolevulinate dehydratase. Biochem J. 1985 ; 225: 573-580
24. Malhotra A, Nair P, Dhawan DK. Curcumin and resveratrol synergistically stimulate p21 and regulate cox 2 by maintaining adequate zinc levels during lung carcinogenesis. Eur J Canc Prev. 2011 ; 20 (5). 411-416